Aclaris Therapeutics
ACRS
ACRS
100 hedge funds and large institutions have $536M invested in Aclaris Therapeutics in 2018 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 28 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $703M → $536M (-$168M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $254K
Holders
100
Holding in Top 10
2
Calls
–
Puts
$254K
Top Buyers
| 1 | +$13.1M | |
| 2 | +$8.98M | |
| 3 | +$5.45M | |
| 4 |
D.E. Shaw & Co
New York
|
+$3.77M |
| 5 |
JP Morgan Chase
New York
|
+$3.25M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$2.28M | |
| 3 | -$1.94M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$1.58M |
| 5 |
BlackRock
New York
|
-$1.53M |